Latest News and Press Releases

BOSTON, MA--(Marketwire - June 1, 2009) - REGiMMUNE Corporation today announced that its lead product candidate RGI-2001, in combination with a low-dose of Sirolimus, demonstrated enhanced efficacy...

MOUNTAIN VIEW, CA--(Marketwire - May 12, 2009) - REGiMMUNE Corporation today announced that a company abstract has been accepted for presentation at the 2009 American Transplant Congress (ATC, May 30...

MOUNTAIN VIEW, CA and TOKYO--(Marketwire - December 8, 2008) - REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders,...

MOUNTAIN VIEW, CA and TOKYO--(Marketwire - May 6, 2008) - REGiMMUNE Corporation, a privately held biopharmaceutical company, announced today that it has closed its Series B financing for a total of...

MOUNTAIN VIEW, CA and TOKYO, JAPAN--(Marketwire - August 8, 2007) - REGiMMUNE Corporation, a privately held biopharmaceutical company, announced today it has been awarded a grant from the Japanese...

MOUNTAIN VIEW, CA and TOKYO -- (MARKET WIRE) -- February 21, 2007 -- REGiMMUNE Corporation., a privately held biopharmaceutical company, announced today the appointment of Shirley Liu Clayton as a...

MOUNTAIN VIEW, CA and TOKYO -- (MARKET WIRE) -- February 21, 2007 -- REGiMMUNE Corporation., a privately held biopharmaceutical company, announced today that it has raised $4.2 million U.S. in a...